MariMed COO exercises RSUs, covers tax with shares
MariMed Inc. Chief Operating Officer Timothy Shaw exercised restricted stock units into common stock.
Rhea-AI Filing Summary
MariMed Inc. Chief Operating Officer Timothy Shaw exercised restricted stock units into common stock. On April 2, 2026, 9,982 RSUs converted to 9,982 shares of common stock on a one-for-one basis, increasing his direct holdings.
Of these shares, 3,459 were withheld by MariMed to cover tax withholding obligations, leaving Shaw with 9,357,700 shares of common stock held directly. Separately, 2,000,000 shares are held indirectly by the Shaw Family Trust for the benefit of his children, and he disclaims beneficial ownership of those securities. The RSU grant continues, with 9,981 RSUs scheduled to vest on October 2, 2026, and 9,982 RSUs on April 2, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
9,982 shares exercised/converted
Exercise
4 txns
Insider
Shaw Timothy
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) | 9,982 | $0.00 | $0.00 |
| Exercise | Common stock | 9,982 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common stock | 3,459 | $0.0691 | $239.02 |
| holding | Common stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units (RSU) — 19,963 contracts (Direct);
Common stock — 9,357,700 shares (Direct);
Common stock — 2,000,000 shares (Indirect, By the Shaw Family Trust)
Footnotes (4)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. These RSUs were granted on April 2, 2024; of the remaining RSUs under this grant, 9,981 will vest on October 2, 2026, and 9,982 will vest on April 2, 2027 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Key Figures
RSUs exercised: 9,982 RSUs
Shares withheld for taxes: 3,459 shares at $0.0691
Direct common stock holdings: 9,357,700 shares
+3 more
6 metrics
RSUs exercised
9,982 RSUs
Converted to common stock on April 2, 2026
Shares withheld for taxes
3,459 shares at $0.0691
Withheld to satisfy tax obligations on RSU vesting
Direct common stock holdings
9,357,700 shares
Shares of MariMed common stock held directly after transactions
Indirect trust holdings
2,000,000 shares
Common stock held by the Shaw Family Trust; beneficial ownership disclaimed
Future RSU vesting
9,981 RSUs
Scheduled to vest on October 2, 2026 from April 2, 2024 grant
Future RSU vesting
9,982 RSUs
Scheduled to vest on April 2, 2027 from same RSU grant
Key Terms
Restricted Stock Units (RSU), tax withholding obligations, irrevocable trust, Section 16, +1 more
5 terms
Restricted Stock Units (RSU) financial
"security_title: Restricted Stock Units (RSU)"
tax withholding obligations financial
"withheld by the Issuer to satisfy tax withholding obligations"
irrevocable trust financial
"The trust is an irrevocable trust."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
Shaw Family Trust financial
"nature_of_ownership: By the Shaw Family Trust"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MariMed (MRMD) COO Timothy Shaw do in this Form 4 filing?
Timothy Shaw exercised 9,982 restricted stock units into common stock at MariMed. These RSUs converted one-for-one into shares, increasing his direct ownership, with a portion of the new shares withheld by the company to satisfy tax withholding obligations related to the vesting event.
What are the future vesting terms of Timothy Shaw’s MariMed (MRMD) RSUs?
The RSUs were originally granted on April 2, 2024. Of the remaining units under this grant, 9,981 RSUs are scheduled to vest on October 2, 2026, and another 9,982 RSUs are scheduled to vest on April 2, 2027, subject to the award agreement terms.
Were any MariMed (MRMD) derivative securities remaining after Timothy Shaw’s RSU exercise?
The derivative position summary shows no remaining derivative securities in this filing. However, the footnotes clarify that additional RSUs from the April 2, 2024 grant will vest in tranches on October 2, 2026 and April 2, 2027, under the existing award agreement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
